This site uses cookies. By continuing to browse the site you are agreeing to our use of cookies.  Read our Cookies Policy.
Close
Eye News
  • Features
    • Close
    • Features
    • Allied Professions
    • Humanitarian
    • Interviews
    • AI & Oculomics
    • Ophthalmology
    • Optometry
    • Podcast videos
    • Supplements
  • Education
    • Close
    • Education
    • Learning Curve
    • Quiz
    • Top Tips
    • Trainees
    • Medico-Legal
    • The Truth Behind The Headlines
    • Case Reports
    • Pete's Bogus Journey
  • Reviews
    • Close
    • Reviews
    • Book Reviews
    • Journal Reviews
    • What's trending?
    • Tech Reviews
    • My Top Five
    • The Culture Section
  • Events
  • News
  • Product Guide
  • Industry News
  • Contact us
    • Close
    • Contact us
    • Write for Eye News
  • Home
  • Reviews
  • Journal Reviews
  • Outcomes of punch punctoplasty with Kelly punch

Outcomes of punch punctoplasty with Kelly punch
Reviewed by Sofia Rokerya

1 August 2017 | Sofia Rokerya | EYE - Pathology, EYE - Oncology

The authors report a retrospective case series study, over an eight-year period between January 2008 to January 2016 evaluating the long-term outcomes of punch punctoplasty by Kelly punch as a primary treatment for punctal stenosis; 101 punch punctoplasties from 50 patients were evaluated. Anatomical success was defined by well-patent puncta on follow-up. Functional success was considered complete if tearing resolved completely postop and partial if residual tearing remained despite patent puncta and drainage system. There was a female predisposition, with 36 women and 14 men in the study. The mean age at presentation was 59 years (range three to 86 years). Bilateral stenosis was noted in 30% (15/50) of the patients. All patients presented with tearing. The majority of cases in the series (69%; 70/101) had grade 1 stenosed puncta, followed by 27% (27/101) of grade 2 size and 4% (4/101) with grade 0 punctal atresia. Mean punctal grading was 1.14+/-0.5. At a mean follow-up of 34 months (range: six to 86 months), the anatomical success rate was 94% (95 out of 101 puncta), whereas functional success rate was 92% (54 out of 59 eyes). Two cases experienced postop dry eyes; otherwise no major complication was observed. Anatomical success was maintained in 94% (95/101) at six months follow-up. The three eyes with punctal restenosis showed evidence of restenosis by one month postop. Thirty-five cases available for long-term follow-up of more than one year (range 12 to 86 months), showed well patent puncta at one month up to latest follow-up. No cases required reoperation or secondary procedures in the series. Literature review showed a competitive edge of punch punctoplasty compared with other punctoplasty techniques. Compared with the variable rates of success with the snip procedure, quoted to range from 31.2 to 92%, the success rate with punch punctoplasty was found to be superior. It was comparable to the success rates of combined procedures with bicanalicular stents or mini-monoka stent, avoiding increased operating time, patient discomfort, infection rate, and the likely possibility of complications such as stent displacement. The authors advocate that punch punctoplasty via Kelly punch is a simple, minimally invasive procedure that demonstrates high anatomical and functional success as a sole primary treatment for simple punctal stenosis. Limitations of the study: Retrospective nature and the lack of a standardised objective method to assess epiphora symptoms quantitatively.

Long-term outcomes of punch punctoplasty with Kelly punch.
Wong ES, Li EY, Yuen HK.
EYE (LOND)
2017;31(4):560-5.
Share This
Sofia Rokerya
CONTRIBUTOR
Sofia Rokerya

MBBS MRCOphth FRCSI, King's College University Hospital, UK.

View Full Profile
Specialty
  • EYE - Cataract
  • EYE - Cornea
  • EYE - General
  • EYE - Glaucoma
  • EYE - Neuro-ophthalmology
  • EYE - Oculoplastic
  • EYE - Oncology
  • EYE - Orbit
  • EYE - Paediatrics
  • EYE - Pathology
  • EYE - Refractive
  • EYE - Strabismus
  • EYE - Vitreo-Retinal
Archive
  • 2025
  • 2024
  • 2023
  • 2022
  • 2021
  • 2020
  • 2019
  • 2018
  • 2017
  • 2016
  • 2015
  • 2014
  • 2013

Top Of Page

9 Gayfield Square, 
Edinburgh EH1 3NT, UK.

Call: +44 (0)131 557 4184
www.pinpoint-scotland.com

WEBSITE DETAILS
  • Cookie Policy
  • Data Protection Notice
  • Privacy Policy
  • Terms and Conditions
ABOUT US
  • Who we are
  • Register
  • Contact us
  • Contributors
  • Company Awards
DIGITAL ISSUES/GUIDELINES
  • Digital issues - Library
  • Supplements - Library
  • Guidelines
Accreditations
IPSO_FLAG_TEAL 2025.png cpdcertified.png

Pinpoint Scotland Ltd (Registered in Scotland No. SC068684) | © 2025 - Website by Gecko Agency